Polina Babenkova

Ms. Polina Babenkova

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2025 in Exploration of Neuroprotective Therapy
Verified
Journal Article
Open access
PDF file
EKEkaterina P. Krutskikh
Ekaterina P. Krutskikh
PBPolina Babenkova
Polina Babenkova
VNVeronika Nesterova
Veronika Nesterova
ATArina D. Tsvetkova
Arina D. Tsvetkova
IBInna Burakova
Inna Burakova
AGArtem Gureev
Artem Gureev
Aim: Systemic inflammation is a key factor in cognitive decline and neurodegenerative diseases. Polyphenols, such as curcumin, resveratrol, and salidroside, exhibit neuroprotective effects, but their low bioavailability raises questions about their mechanism of action. The gut-brain axis, mediated by microbiome modulation, may play a critical role in their cognitive benefits. This study investigated whether polyphenols (curcumin, resveratrol, and salidroside) improve cognitive function in mice with lipopolysaccharide (LPS)-induced gut inflammation by modulating the gut microbiome and reducing neuroinflammation. Methods: C57BL/6 mice were divided into five groups: control, LPS, and LPS + polyphenol treatments (curcumin, resveratrol, or salidroside). LPS was administered intraperitoneally to induce inflammation, while polyphenols were given orally for three weeks. Cognitive performance was assessed using the Morris water maze. Gut microbiome composition (16S rRNA sequencing), mitochondrial DNA (mtDNA) damage, and gene expression in brain regions were analyzed. Results: LPS impaired spatial memory, but resveratrol and salidroside significantly mitigated these deficits. Polyphenols restored beneficial bacteria (e.g., Alloprevotella, Eubacterium) and suppressed pathogenic taxa (e.g., Peptostreptococcales). They also reduced pro-inflammatory markers in the cortex and hippocampus. Curcumin showed weaker effects. No significant mtDNA damage was detected. Conclusions: Polyphenols, particularly resveratrol and salidroside, improve cognition during systemic inflammation by remodeling the gut microbiome and attenuating neuroinflammation. These findings highlight the gut-brain axis as a therapeutic target for inflammation-driven cognitive disorders.

26 July 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
PBPolina Babenkova
Polina Babenkova
AGArtem P. Gureev
Artem P. Gureev
ISIrina Sadovnikova
Irina Sadovnikova
IBInna Burakova
Inna Burakova
YDYuliya Dmitrievna Dvoretskaya
Yuliya Dmitrievna Dvoretskaya
MSMikhail Syromyatnikov
Mikhail Syromyatnikov
L-carnitine and Mildronate are substances that can significantly rearrange the energy metabolism of cells. This can potentially cause changes in the bacterial composition of the gut microbiome and affect testis functionality and male sexual health. Mice of the C57Bl/6 line were used. Sexual behavior was assessed using physiological tests, and gene expression patterns were assessed by qPCR. High-throughput sequencing of mouse fecal microbiota was performed. We showed that long-term administration of Mildronate has no significant effect on the intestinal microbiome, and there was a compensatory increase in the expression of genes involved in fatty acid and leptin metabolism. No impairment of sexual motivation in male mice was observed. Prolonged L-carnitine supplementation caused a decrease in alpha diversity of bacteria and a decrease in some groups of microorganisms that are components of a healthy gut microflora. A correlation was observed between the level of bacteria from Firmicutes phylum, indicators of sexual motivation of mice, and the dynamics of body weight gain. Our results may indicate that metabolic modulators can have a significant impact on the structure of the bacterial community of the gut microbiome, which may influence male sexual health through the gut–semen axis.

29 September 2026 in Current Neuropharmacology
Verified
Journal Article
Closed access
PDF file
VNVeronika Nesterova
Veronika Nesterova
DADianna Adzhemian
Dianna Adzhemian
VGViktoria Gribovskaya
Viktoria Gribovskaya
PBPolina Babenkova
Polina Babenkova
MIMikhail Ivanov
Mikhail Ivanov
Denis N. SilachevDenis N. Silachev
Denis N. Silachev
Introduction: Traumatic brain injury (TBI) frequently results in persistent cognitive deficits driven by secondary mechanisms including mitochondrial dysfunction, oxidative stress, and neuroinflammation. We compared the effects of L-carnitine and mildronate on spatial memory recovery after TBI and investigated the underlying cellular mechanisms. Methods: Male C57BL/6 mice were subjected to controlled cortical impact TBI and assigned to naïve, sham, TBI+saline, TBI+mildronate (100 mg/kg/day), or TBI+L-carnitine groups. Spatial working memory was evaluated using the Morris water maze over 21 days. At 24 days post-injury, we measured cortical and hippocampal malondialdehyde (MDA), mtDNA integrity and copy number, expression of genes related to mitochondrial biogenesis, glucose metabolism, angiogenesis, and neuroinflammation, and performed blood cytology. Results: TBI induced significant memory deficits, elevated MDA, and reduced mtDNA copy number without increased damage. Mildronate, but not L-carnitine, significantly improved cognitive performance. Mildronate upregulated Tfam, Glut4, Cd34, and Eng while downregulating Gfap in the hippocampus. Both compounds decreased MDA and circulating cell-free mtDNA. Discussion: Mildronate’s superior neuroprotection appears to involve enhanced mitochondrial biogenesis, glucose transport, and angiogenesis, alongside suppression of astrogliosis. In contrast, L-carnitine showed limited cognitive benefit, possibly due to insufficient mitochondrial renewal and vascular repair. Conclusion: Mildronate exerts greater neuroprotective effects than L-carnitine after TBI, likely via coordinated restoration of mitochondrial quality control, glucose utilization, and vascular remodeling, offering a promising strategy to mitigate post-traumatic cognitive decline.

2 September 2026 in Reproductive Toxicology
Verified
Journal Article
Closed access
PBPolina Babenkova
Polina Babenkova
NGNadezhda A. Golovina
Nadezhda A. Golovina
VRVictoria N. Reprintseva
Victoria N. Reprintseva
SKSofya O. Karaulova
Sofya O. Karaulova
AVAlena D. Vostrikova
Alena D. Vostrikova
MSMikhail Yu. Syromyatnikov
Mikhail Yu. Syromyatnikov

30 December 2025
Verified
Closed access
PDF file
PBPolina Babenkova
Polina Babenkova
VNVeronika V. Nesterova
Veronika V. Nesterova
ATArina D. Tsvetkova
Arina D. Tsvetkova
AEAnna A. Eremina
Anna A. Eremina
VKVera A. Kryukova
Vera A. Kryukova
AGArtem P. Gureev
Artem P. Gureev